Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal morphine dose comparison in laparoscopic colorectal surgery
ChiCTR2200065531Phase 4Not yet recruiting
- Sponsor
- Fujian Provincial Hospital
- Start
- Nov 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of morphine and ropivacaine in postoperative pain and colorectal cancer (CRC) (4 arms), sponsored by Fujian Provincial Hospital. Primary endpoint: Quality of Recovery-15 score at 24 hours. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
morphineropivacaine
03
Conditions
postoperative paincolorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2200065531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065531.